Day Trading 14 Sept Pre Market, page-22

EVE

"International Distribution Omniblend Innovation has recently entered into a Memorandum of Understanding (“MOU”) with Chinese company Beijing Dongfang Hongsheng International Biotechnology Development Co. Ltd (“DFHS”). The MOU provides the framework for the parties to enter into a definitive agreement on the registration, marketing and sales in China of GlucoSmooth™, Omniblend Innovation’s pre-meal technology targeting people living with Type 2 Diabetes."